Tuberculosis: Is it the main cause of pleural effusion in patients of Kabul city, Afghanistan?

Main Article Content

Mohammad Jawad Jawad
Ali Nawrozie
Nizahat Mahdawi


Introduction: Pleural effusion is one of the most common pleural diseases, and its causes are various cardiovascular, lung, kidney, cancer, and infectious diseases.

Materials and methods: The present study was carried out in the year 2018 at Sadri Ibn Sina Hospital, involving a total of 4564 patients. Out of these, a specific focus was given to 100 patients diagnosed with pleural effusion. Demographic details, such as age, gender, marital status, causes of effusion, occupation, place of residence, effusion location, type of fluid, and any existing comorbidities, were gathered and analyzed using the SPSS software.

Results: Based on the findings of this study, tuberculosis accounts for 49% of the cases, pneumonia for 13%, congestive heart failure for 12%, corpulmonary disease for 11%, cancer for 10%, and chronic kidney failure for 4%. Additionally, 1% of the cases experienced pleural embolism as a result of pulmonary embolism. In regards to the liquid type, 77% of it was transudative, while 23% was exudative.

Disscusion: Pleural effusion refers to the abnormal buildup of fluid in the pleural cavity, typically caused by either an overproduction of fluid or a compromised lymphatic system's ability to absorb it. This research has firmly established infection, with tuberculosis being the most significant factor, as the leading cause of this condition.

Article Details

How to Cite
Jawad, M. J., Nawrozie, A., & Mahdawi, N. (2024). Tuberculosis: Is it the main cause of pleural effusion in patients of Kabul city, Afghanistan?. Afghanistan Journal of Infectious Diseases, 2(2), 35–40.
Research Article


Parikh P, Odhwani J, Ganagajalia C. Study of 100 cases of pleural effusion with reference to diagnostic approach. Int J Adv Med. 2016;3(2):328-31.

Karkhanis VS, Joshi JM. Pleural effusion: diagnosis, treatment, and management. Open access emergency medicine: OAEM. 2012;4:31.

Zahedi S, Carvalho AS, Ejtehadifar M, Beck HC, Rei N, Luis A, et al. Assessment of a Large-Scale Unbiased Malignant Pleural Effusion Proteomics Study of a Real-Life Cohort. Cancers. 2022;14(18):4366.

Karkhanis VS, Joshi JM. Pleural effusion: diagnosis, treatment, and management. Open Access Emerg Med. 2012;4:31-52.

Dipper A, Sundaralingam A, Hedley E, Tucker E, White P, Bhatnagar R, et al. The randomised thoracoscopic talc poudrage+ indwelling pleural catheters versus thoracoscopic talc poudrage only in malignant pleural effusion trial (TACTIC): study protocol for a randomised controlled trial. BMJ Open Respiratory Research. 2023;10(1):e001682.

Organization WH. Global tuberculosis report 2013: World Health Organization; 2013.

Baumann MH, Nolan R, Petrini M, Lee YG, Light RW, Schneider E. Pleural tuberculosis in the United States: incidence and drug resistance. Chest. 2007;131(4):1125-32.

Diacon A, Van de Wal B, Wyser C, Smedema J, Bezuidenhout J, Bolliger C, et al. Diagnostic tools in tuberculous pleurisy: a direct comparative study. European Respiratory Journal. 2003;22(4):589-91.

Skouras VS, Kalomenidis I. Drug resistance in patients with tuberculous pleural effusions. Current Opinion in Pulmonary Medicine. 2018;24(4):374-9.

Light RW. Update on tuberculous pleural effusion. Respirology. 2010;15(3):451-8.

Gopi A, Madhavan SM, Sharma SK, Sahn SA. Diagnosis and Treatment of Tuberculous Pleural Effusion in 2006. Chest. 2007;131(3):880-9.

Berger HW, Mejia E. Tuberculous pleurisy. Chest. 1973;63(1):88-92.

Valdes L, Pose A, San José E, Vázquez JMMn. Tuberculous pleural effusions. European journal of internal medicine. 2003;14(2):77-88.

Shaw JA, Diacon AH, Koegelenberg CF. Tuberculous pleural effusion. Respirology. 2019;24(10):962-71.